Moder KG.New medications for use in patients with rheumatoid arthritis.Annals of Allergy Asthma Immunology. 2000Moder KG. New medications for use in patients with rheumatoid arthritis[J].Annals of Allergy,Asthma & Immunology,2000.280-287.Moder,KG.New medications for use in patients with rheumatoid ...
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne
Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide); or oral compounds inhibiting dipeptidyl peptid...
Getting a good start in taking new medications for a chronic disease constitutes a crucial step in the establishment of continuous medical treatment. Patients in this phase report problems such as concerns about their new medication, side effects and practical problems, all contributing to the risk ...
Reaffirming the JAMA Network Commitment to the Health of Patients and the Public Kirsten Bibbins-Domingo, PhD, MD, MAS; Robert O. Bonow, MD, MS; Neil M. Bressler, MD; Linda Brubaker, MD, MS; Dimitri Christakis, MD, MPH; Stacy L. Christiansen, MA; Gregory Curfman, MD; Mary L. (...
To be nationally ranked in a specialty, a hospital must excel in caring for the sickest, most medically complex patients. Nearby Hospitals ADHospital for Special Surgery New York, NY 0.2 miles away Book Appointment ADMemorial Sloan Kettering Cancer Center New York, NY 0.1 miles away Book ...
treatmenthas come a long way. With daily medication, most people with HIV can live a normal life span. But unmet needs still remain. Some people, for example, find it hard to remember to take their medicine every day. Others develop drug-resistant strains of HIV that make medications ...
Even though new drugs will help to improve the prognosis of people with DKD, it becomes more and more a challenge for physicians to choose the most beneficial medication or combination of medications for an individual patient. There is a need to evaluate the kidney-protective effects of ...
An evaluation of patients' adherence with hypoglycemic medications among Papua New Guineans with type 2 diabetes: influencing factors. Patient Preference & AdherencePihau-Tulo ST, Parsons RW, Hughes JD. An evaluation of patients' adherence with hypoglycemic medications among Papua New ... S Pi...
19 These unnecessary tablets represent a risk not only to patients but also to the community through diversion if not properly managed given that 20% of patients report sharing prescription medications.25 Increased standardization should be considered to reduce individual and societal consequences of ...